Related Experiment Video

Updated: Aug 8, 2026

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatants

Fernando M Trejo1, Jessica Minnaard, Pablo F Perez

  • 1Centro de Investigación y Desarrollo en Criotecnología de Alimentos (CIDCA), 47 y 116 (1900). Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata, Argentina.

Anaerobe
|June 9, 2006
PubMed

Insights

Extracellular factors from infant bifidobacteria inhibit Clostridium difficile growth and adhesion. These findings highlight bifidobacteria

Area of Science:

  • Microbiology
  • Gastroenterology
  • Probiotics

Background:

  • Clostridium difficile infection (CDI) is a significant healthcare concern.
  • The gut microbiome plays a crucial role in host defense against pathogens.
  • Bifidobacteria are key commensal bacteria in the infant gut microbiome.

Purpose of the Study:

  • To investigate the antimicrobial and anti-adhesive properties of bifidobacterial extracellular factors against Clostridium difficile.
  • To identify specific Bifidobacterium strains with potential to antagonize C. difficile virulence.

Main Methods:

  • Testing antimicrobial effects using agar-diffusion assays.
  • Evaluating anti-adhesive properties by co-culturing C. difficile with human enterocytes (Caco-2/TC7).
  • Characterizing the nature of the anti-adhesive factors (thermolability, pH activity, protease sensitivity).

Main Results:

  • Bifidobacterial supernatants demonstrated strain-dependent growth inhibition of C. difficile.
  • Six Bifidobacterium strains produced extracellular factors that antagonized C. difficile adhesion to enterocytes.
  • The anti-adhesive factors were thermolabile, active at neutral pH, and resistant to proteolytic cleavage.

Conclusions:

  • Selected bifidobacteria possess extracellular factors that can inhibit C. difficile growth and adhesion.
  • These findings suggest a potential role for specific bifidobacteria in preventing or managing C. difficile infections.
  • Bifidobacteria may represent a promising probiotic strategy to counteract C. difficile virulence mechanisms.

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...